Valve-in-valve transcatheter aortic valve implantation successfully treated severe bioprosthetic aortic stenosis and resulted in the spontaneous closure of a mitral-aortic intervalvular fibrosa pseudoaneurysm.
Case Report (n=1)
No
ViV-TAVI may be an effective treatment for degenerated surgical bioprosthesis complicated by MAIVF pseudoaneurysm, potentially leading to spontaneous closure of the pseudoaneurysm.
Valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) is a minimally invasive and effective alternative to redo surgery in high-risk patients with degenerated surgical bioprosthetic valves. We report a 67-year-old woman with a history of Bentall and redo Bentall procedures who presented with degeneration of a surgical bioprosthesis complicated by a mitral-aortic intervalvular fibrosa (MAIVF) pseudoaneurysm. ViV-TAVI resulted in marked symptomatic improvement and optimal hemodynamic valve performance and was unexpectedly associated with spontaneous closure of the MAIVF pseudoaneurysm.
Balaban et al. (Fri,) conducted a case report in Degenerated surgical bioprosthesis and mitral-aortic intervalvular fibrosa pseudoaneurysm (n=1). Valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) was evaluated on Symptomatic improvement, hemodynamic valve performance, and closure of pseudoaneurysm. Valve-in-valve transcatheter aortic valve implantation successfully treated severe bioprosthetic aortic stenosis and resulted in the spontaneous closure of a mitral-aortic intervalvular fibrosa pseudoaneurysm.